Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gasparini

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Journal of the American Chemical Society|December 15, 2006
Structure-based secondary structure-independent approach to design protein ligands: Application to the design of Kv1.2 potassium channel blockersC Magis, D Gasparini, A Lecoq, et al.
In Vivo (Athens, Greece)|January 6, 2007
A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response ratesR Mancini, L Carpanese, R Sciuto, et al.
The Journal of Cardiovascular Surgery|April 6, 2013
BRAVISSIMO: 12-month results from a large scale prospective trialM Bosiers, K Deloose, J Callaert, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Journal of the American Chemical Society|December 15, 2006
Structure-based secondary structure-independent approach to design protein ligands: Application to the design of Kv1.2 potassium channel blockersC Magis, D Gasparini, A Lecoq, et al.
In Vivo (Athens, Greece)|January 6, 2007
A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response ratesR Mancini, L Carpanese, R Sciuto, et al.
The Journal of Cardiovascular Surgery|April 6, 2013
BRAVISSIMO: 12-month results from a large scale prospective trialM Bosiers, K Deloose, J Callaert, et al.
Pageof 6